Name: Acute effects of betahistine hydrochloride on energy homeostasis in obese women. - 4/11/2012
Start: 2012-04-11T07:30:00
End: 2012-04-11T07:30:00
Location: 4727 Cramblett Hall

Wednesday, April 11, 2012 at 7:30 AM

This grand round has already taken place.

4727 Cramblett Hall - Columbus, OH

April 11^th, 2012

1.00 AMA PRA Category 1 Credit^™ Hours

Description

According to the Centers for Disease Control and Prevention, there is an increasing prevalence of common endocrine diseases such as diabetes. Other endocrine diseases that have seen an increased prevalence are thyroid disorders, thyroid cancer and lipid disorders. The use of sophisticated technologies allows early detection and there are many emerging changes in diagnosis of endocrine disorders. It is important for endocrinologists to understand the complexities of the relationship between genetic and environmental diseases while integrating new, innovative therapies for treating these disorders. This series will address the breaking, cutting edge clinical and basic research related to endocrine disorders to further address this growing patient care issue.

Dates and Times

Start: 4/11/2012 7:30 AM
End: 4/11/2012 7:30 AM

Objectives

1. Review effect of manipulation of histamine receptors on energy homeostasis 2. Present research data using betahistine (H1 receptor agonist) on energy homeostasis in obese females.

Speakers

Asem Ali, MBBS
- Acute effects of betahistine hydrochloride on energy homeostasis in obese women.

Location

4727 Cramblett Hall
456 W 10th Ave
Columbus, OH 43210

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ^™. Physicians should only claim credit commensurate with the extent of their participation in the activity.